Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | KCNA3 | P22001 | 3/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | PAM | P19021 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931967 | 1.00 | GRIN1 (0.49) | GRIN1GRIN2BMAOBLMNAALDH1A1 | |
| SCHEMBL29804851 | 0.92 | MAOB (0.54) | GRIN1GRIN2BMAOBLMNAMEN1 | |
| SCHEMBL8333012 | 0.92 | MAOB (0.54) | GRIN1GRIN2BMAOBLMNAMEN1 | |
| SCHEMBL16052780 | 0.92 | MAOB (0.54) | GRIN1GRIN2BMAOBLMNAMEN1 | |
| SCHEMBL3851041 | 0.90 | AHR (0.46) | ALDH1A1KCNA3IDO1 | |
| SCHEMBL10602496 | 0.90 | AHR (0.46) | ALDH1A1KCNA3IDO1 | |
| SCHEMBL4256257 | 0.85 | MAOB (0.67) | MAOBALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL1892917 | 0.85 | MAOB (0.67) | MAOBALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL163963 | 0.85 | MAOB (0.67) | MAOBALDH1A1MEN1KMT2AKDM4E | |
| Fluoride SCHEMBL28109078 | 0.83 | MAOB (0.64) | GRIN1GRIN2BMAOBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656985-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656986-B2 | Compositions comprising TPGS-750-M | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656985-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656986-B2 | Compositions comprising TPGS-750-M | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656985-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656986-B2 | Compositions comprising TPGS-750-M | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECH LLC (US) | 2016-12-01 | — | — | US | disclosed |
| US-8785665-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| US-8785665-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| US-8785665-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| CN-102892504-A | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL HOLDINGS LTD | 2013-01-23 | — | — | CN | disclosed |
| EP-2506970-A1 | SURFACTANT-ENABLED TRANSITION METAL-CATALYZED CHEMISTRY | Mycell Holdings Limited (US) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011068895-A1 | SURFACTANT-ENABLED TRANSITION METAL-CATALYZED CHEMISTRY | MyCell Holdings Limited (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011068895-A1 | SURFACTANT-ENABLED TRANSITION METAL-CATALYZED CHEMISTRY | MyCell Holdings Limited (US) | 2011-06-09 | — | — | WO | disclosed |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MyCell Holdings Limited | 2011-06-02 | — | — | US | disclosed |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MyCell Holdings Limited | 2011-06-02 | — | — | US | disclosed |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MyCell Holdings Limited | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | GRIN1 1382/4885GRIN2B 3048/4885MAOB 4159/4885 |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | GRIN1 1382/4885GRIN2B 3048/4885MAOB 4159/4885 |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | GRIN1 1382/4885GRIN2B 3048/4885MAOB 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.